Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection
Tristan Ferry, Camille Kolenda, Frédéric Laurent, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Stephen Wood, Timothy M. Kuzel, Sasha H. Shafikhani
Cells (2023) Vol. 12, Iss. 1, pp. 199-199
Open Access | Times Cited: 129
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study
Jean‐Paul Pirnay, Sarah Djebara, Griet Steurs, et al.
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1434-1453
Open Access | Times Cited: 91
Drug delivery systems based on polyethylene glycol hydrogels for enhanced bone regeneration
Shouye Sun, Yutao Cui, Baoming Yuan, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 79
The Medicinal Phage—Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation
Timo Faltus
Viruses (2024) Vol. 16, Iss. 3, pp. 443-443
Open Access | Times Cited: 17
Phage-antibiotic combinations to control Pseudomonas aeruginosa–Candida two-species biofilms
Prasanth Manohar, Belinda Loh, N. Ramesh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Phage therapy
Mikael Skurnik, Sivan Alkalay‐Oren, Maarten Boon, et al.
Nature Reviews Methods Primers (2025) Vol. 5, Iss. 1
Closed Access | Times Cited: 2
Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa
Thilo Köhler, Alexandre Lüscher, Léna Falconnet, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 37
Combination of genetically diverse Pseudomonas phages enhances the cocktail efficiency against bacteria
Ampapan Naknaen, Thanadon Samernate, Wichanan Wannasrichan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Retrospective, observational analysis of the first one hundred consecutive cases of personalized bacteriophage therapy of difficult-to-treat infections facilitated by a Belgian consortium
Jean‐Paul Pirnay, Sarah Djebara, Griet Steurs, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 26
Phage Therapy as a Novel Therapeutic for the Treatment of Bone and Joint Infections
Gina A. Suh, Tristan Ferry, Matthew P. Abdel
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S407-S415
Open Access | Times Cited: 22
Navigating Antibacterial Frontiers: A Panoramic Exploration of Antibacterial Landscapes, Resistance Mechanisms, and Emerging Therapeutic Strategies
Krittika Ralhan, Kavita A. Iyer, Leilani Lotti Díaz, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 5, pp. 1483-1519
Open Access | Times Cited: 14
Bacteriophage Therapy and Current Delivery Strategies for Orthopedic Infections: A SCOPING Review
Jason Young, Sang Won Lee, Mohammad Javad Shariyate, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106125-106125
Open Access | Times Cited: 8
Bacteriophage therapy for human musculoskeletal and skin/soft tissue infections
Willem‐Jan Metsemakers, Jolien Onsea, T. Fintan Moriarty, et al.
Clinical Microbiology and Infection (2023) Vol. 29, Iss. 6, pp. 695-701
Open Access | Times Cited: 17
Phage therapy as a glimmer of hope in the fight against the recurrence or emergence of surgical site bacterial infections
Majid Taati Moghadam, Ali Mojtahedi, Shakiba Salamy, et al.
Infection (2024) Vol. 52, Iss. 2, pp. 385-402
Closed Access | Times Cited: 7
Phage Delivery Strategies for Biocontrolling Human, Animal, and Plant Bacterial Infections: State of the Art
Marta M. D. C. Vila, Liliane M. N. Balcão, Victor M. Balcão
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 374-374
Open Access | Times Cited: 6
Current status of bacteriophage therapy for severe bacterial infections
Teiji Sawa, Kiyoshi Moriyama, Mao Kinoshita
Journal of Intensive Care (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Antibody‐Drug Conjugates to Treat Bacterial Biofilms via Targeting and Extracellular Drug Release
Anne Tvilum, Mikkel Illemann Johansen, Lærke N. Glud, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 14
Magistral Phage Preparations: Is This the Model for Everyone?
Jean‐Paul Pirnay, Gilbert Verbeken
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_5, pp. S360-S369
Open Access | Times Cited: 14
Pseudomonas aeruginosa two-component system CprRS regulates HigBA expression and bacterial cytotoxicity in response to LL-37 stress
Yingjie Song, Siping Zhang, Ninglin Zhao, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 1, pp. e1011946-e1011946
Open Access | Times Cited: 5
Does Phage Therapy Need a Pan-Phage?
Petros Bozidis, Eleftheria Markou, Athanasia Gouni, et al.
Pathogens (2024) Vol. 13, Iss. 6, pp. 522-522
Open Access | Times Cited: 5
Phage therapy for bone and joint infections: A comprehensive exploration of challenges, dynamics, and therapeutic prospects
Jiaze Peng, Caopei Guo, Chengbing Yang, et al.
Journal of Global Antimicrobial Resistance (2024) Vol. 39, pp. 12-21
Open Access | Times Cited: 5
Decoding antibiotic resistance in Pseudomonas aeruginosa: Embracing innovative therapies beyond conventional antibiotics
Nomita Gupta, Kanchan Chauhan, Garima Singh, et al.
The Microbe (2025), pp. 100233-100233
Open Access
Mucosal-adapted bacteriophages as a preventive strategy for a lethal Pseudomonas aeruginosa challenge in mice
Luiz Felipe Leomil Coelho, Mateus de Souza Terceti, Sergio Pereira Lima Neto, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
The pharmaceutical quality of freeze-dried tablets containing therapeutic bacteriophages against Pseudomonas aeruginosa and Staphylococcus aureus
Marie Komárková, Martin Benešík, Eva Černá, et al.
International Journal of Pharmaceutics (2025), pp. 125199-125199
Open Access
Enhanced suppression of Stenotrophomonas maltophilia by a three-phage cocktail: genomic insights and kinetic profiling
Alisha N. Monsibais, Olivia Tea, Pooja Ghatbale, et al.
Antimicrobial Agents and Chemotherapy (2025) Vol. 69, Iss. 3
Open Access
Page 1 - Next Page

Scroll to top